Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
113NH3 PET/CT scan----1件: 84
218F-DOPA PET----1件: 6
318FDG PET/CT scan----1件: 84
468Ga-DOTA-TATE PET/MR and PET/CT imaging1件: Dotatate---1件: 238
568Ga-DOTATATE PET/CT2件: Dotatate,
Dotatate gallium Ga-68		---1件: 84
6[18F] LBT-999 PET----1件: 6
7[18F]-FLT-PET/CT scans----1件: 34
8[18F]DPA-714 PET----1件: 2
9[18F]DPA-714 PET scan----1件: 6
10[18F]FDOPA PET/CT----1件: 6
11[18F]Florbetapir PET imaging----1件: 13
12[18F]FPEB PET imaging----1件: 206
13[C11]PK-1195 PET scan----1件: 13
14[Zr-89]Oxine-labeled leukocytes PET/MR1件: Oxyquinoline1件: D05321 --1件: 13
15Brain PET scan----3件: 5, 7, 127
16Cellulose acetate with petrolatum3件: Acetate,
Microcrystalline cellulose,
Petrolatum		2件: D00093 ,
D05331 (Name: Petrolatum)		--2件: 35, 162
17Combination Product: 68Ga-DOTATATE PET/CT2件: Dotatate,
Dotatate gallium Ga-68		---1件: 238
18Cotton gauze with petrolatum2件: Cotton,
Petrolatum		1件: D05331 (Name: Petrolatum)--2件: 35, 162
19Diagnostic Test: 11C-UCB-J PET-CT----1件: 8
20Diagnostic Test: 18F-FDG and 68Ga-FAPI PET/CT1件: Fludeoxyglucose (18F)---1件: 96
21Diagnostic Test: 18F-FDG PET-MR1件: Fludeoxyglucose (18F)---1件: 8
22Diagnostic Test: 18F-FDG-PET/MRI1件: Fludeoxyglucose (18F)---1件: 84
23Diagnostic Test: 18F-GE180-PET/MRI----1件: 84
24Diagnostic Test: 68-Ga HA-DOTATATE PET/CT1件: Dotatate---1件: 41
25Diagnostic Test: 68Ga-DOTA-TOC PET/CT----1件: 84
26Diagnostic Test: Entire-body PET-CT scans----1件: 13
27Diagnostic Test: FDG-PET/CT with Rb82 Myocardial Perfusion Imaging----1件: 84
28Diagnostic Test: PET Imaging----1件: 85
29Diagnostic Test: PET with [11C]Flumazenil1件: Flumazenil1件: D00697 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 13
30Diagnostic Test: PET-CT Imaging with [89Zr]-bevacizumab1件: Bevacizumab1件: D06409 1件: VEGFA 💬24件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬1件: 86
31Diagnostic Test: simultaneous combined 18F-FDG PET and cardiac MRI imaging1件: Fludeoxyglucose (18F)---1件: 84
32DPA-714 PET/MRI----1件: 13
33DPA-714-PET/MRI----1件: 6
34ESR-specific PET scan----1件: 86
35FDG-PET----1件: 299
36GE180 PET Scan----1件: 6
37Morphine, buprenorphine, pethidine, tramaldol, metamizole and acetylsalicylacid (Analgesics)4件: Buprenorphine,
Meperidine (Synonym: Pethidine),
Metamizole,
Morphine		8件: D00836 ,
D00842 ,
D01383 (Name: Pethidine hydrochloride (JP18)),
D02271 ,
D07132 ,
D08188 ,
D08233 ,
D08343 (Name: Pethidine)		2件: OPRK1,
OPRM1 💬		3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 298
38MRI, FDG-PET/CT scans----1件: 34
39Other: 18F-FDG PET/CT1件: Fludeoxyglucose (18F)---1件: 41
40Other: 18F-Fluorodeoxyglucose (18F-FDG) PET/CT1件: Fludeoxyglucose (18F)---1件: 84
41Other: [11C]-Methionine PET/MRI1件: Methionine2件: D00019 ,
D04983 		--1件: 75
42Other: [11C]donepezil PET1件: Donepezil2件: D00670 ,
D07869 		1件: ACHE 💬2件: Cholinergic synapse, Glycerophospholipid metabolism 💬1件: 6
43PET----1件: 6
44PET with 11C-Flumazenil1件: Flumazenil1件: D00697 16件: GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬		7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬1件: 13
45PET-MRI with [18F]-Florbetaben and PET-MRI with [18F]-DPA-714----1件: 13
46PET/CT----1件: 6
47PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714----1件: 85
48PET10----1件: 41
49PET3----1件: 41
50Pethidine1件: Meperidine (Synonym: Pethidine)2件: D01383 (Name: Pethidine hydrochloride (JP18)),
D08343 (Name: Pethidine)		1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 298
51Petrolatum1件: Petrolatum1件: D05331 (Name: Petrolatum)--3件: 35, 158, 162
52Radiation: 11C-MET PET/CT Imaging----1件: 53
53Radiation: 18F-FDG PET/CT Imaging1件: Fludeoxyglucose (18F)---1件: 53
54Radiation: [18-Fluorine] Flubatine PET Scan----1件: 6
55Radiation: Cardiac PET imaging using F-18-FDG, N-13 ammonia( NH3)1件: Ammonia1件: D02916 --1件: 88
56Radiation: DOTATATE PET-CT1件: Dotatate---1件: 75
57Radiation: F-DOPA PET CT----1件: 75
58Radiation: FDG PET scan----1件: 85
59Radiation: H215O PET----2件: 6, 17
60Radiation: PET (Positron Emission Tomography) Study----1件: 17
61Radiation: PET with the tracer 11C-PE2I----1件: 6
62Radiation: PET with the tracer 18F-DPA-714----1件: 6
63Radiation: PET/CT Scan----1件: 67
64Radiation: PET/CT Scan: Two PET scans using 1. C-11 HED and 2. N-13 Ammonia or rubidium-822件: Ammonia,
Rubidium		1件: D02916 --1件: 86
65Radiation: PET/MR with [11C]PBR28----1件: 6
66Radiation: Rubidium PET1件: Rubidium---1件: 84
67Radiation: Stress myocardial perfusion PET----1件: 46